BlackRock Japan’s Achillion Pharmaceuticals ACHN Stock Holding History

BlackRock Japan’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$22K	Buy	5,372 +1,894	+54%	+$10.1K	﹤0.01%	1109
2016 Q3	$28K	Buy	3,478 +1,174	+51%	+$9.98K	﹤0.01%	1069
2016 Q2	$18K	Buy	2,304 +1,755	+320%	+$15.1K	﹤0.01%	1186
2016 Q1	$4K	Sell	549 -68	-11%	-$498	﹤0.01%	1384
2015 Q4	$7K	Buy	617 +431	+232%	+$3.92K	﹤0.01%	1308
2015 Q3	$1K	Sell	186 -149	-44%	-$1.21K	﹤0.01%	1256
2015 Q2	$3K	Buy	+335	New	+$3.17K	﹤0.01%	1325
2014 Q4	–	Sell	-5,458	Closed	-$54K	–	1400
2014 Q3	$54K	Buy	+5,458	New	+$50.7K	﹤0.01%	1041
2014 Q2	–	Sell	-14,262	Closed	-$47K	–	1449
2014 Q1	$47K	Buy	14,262 +10,098	+243%	+$35.3K	﹤0.01%	1173
2013 Q4	$14K	Sell	4,164 -22,931	-85%	-$66.5K	﹤0.01%	1261
2013 Q3	$82K	Hold	27,095	–	–	﹤0.01%	1035
2013 Q2	$222K	Buy	+27,095	New	+$207K	﹤0.01%	849

Other funds holding ACHN

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock Japan's ACHN Position: Q4 2016 in Review

BlackRock Japan increased its Achillion Pharmaceuticals (ACHN) stake by 54% in Q4 2016, buying an estimated $10.1K and bringing the position to 5,372 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #1109.

BlackRock Japan first reported a position in ACHN in Q2 2013 and has held it in 12 quarters since. The position peaked at $222K in Q2 2013. 140 funds tracked by Wall St. Rank hold ACHN as of Q4 2016.

BlackRock Japan held 5,372 shares of Achillion Pharmaceuticals worth $22K as of Q4 2016.
BlackRock Japan bought 1,894 Achillion Pharmaceuticals shares in Q4 2016, an estimated $10.1K.
Achillion Pharmaceuticals made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1109 holding.
BlackRock Japan first reported a position in Achillion Pharmaceuticals in Q2 2013 and has held it in 12 quarters since.
BlackRock Japan's Achillion Pharmaceuticals position peaked at $222K in Q2 2013.
140 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.